Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
22.85
-0.60 (-2.56%)
At close: May 12, 2026

SHE:003020 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
285.06413.89439.69502.93642.58654.25
Short-Term Investments
--10.67---
Trading Asset Securities
200.5340.275861.520.120.13
Cash & Short-Term Investments
485.59454.16508.36564.45642.7654.39
Cash Growth
5.02%-10.66%-9.94%-12.17%-1.79%-14.64%
Accounts Receivable
488487.5415.63295.19321.02318.37
Other Receivables
4.794.628.0819.9736.036.08
Receivables
492.79492.12423.7315.16357.05324.45
Inventory
227.63204.5220.48242.91361.76188.86
Prepaid Expenses
--1.411.11--
Other Current Assets
30.6225.4531.5427.5191.0351.95
Total Current Assets
1,2371,1761,1851,1511,4531,220
Property, Plant & Equipment
978.97985.66972.75898.62538.12299.03
Long-Term Investments
204.93196.77194.11180.3914.420.71
Goodwill
74.4474.4474.4474.44--
Other Intangible Assets
95.497.61105.24113.2983.3889.51
Long-Term Deferred Tax Assets
16.1115.8114.5116.138.585.86
Long-Term Deferred Charges
6.493.866.947.417.618.8
Other Long-Term Assets
37.3435.4332.4942.2616.7630.9
Total Assets
2,6502,5862,5862,4842,1211,674
Accounts Payable
366.4349.46347.53301.25460.66242.93
Accrued Expenses
19.9434.5263.1953.9545.2550.5
Short-Term Debt
--5050.05--
Current Portion of Long-Term Debt
-2.54----
Current Portion of Leases
--4.364.5410.03-
Current Income Taxes Payable
29.128.679.0815.5312.716.05
Current Unearned Revenue
27.497.5933.0833.0942.6214.69
Other Current Liabilities
99.2597.8174.7184.3251.3613.88
Total Current Liabilities
542.19520.58581.95542.73622.63328.05
Long-Term Debt
69.6559.6459.6531.01--
Long-Term Leases
1.011.714.572.843.3824.58
Long-Term Unearned Revenue
43.4144.918.2820.1612.9813.24
Long-Term Deferred Tax Liabilities
7.017.368.9313.431.39-
Other Long-Term Liabilities
----1.164.66
Total Liabilities
663.27634.19673.38610.18641.53370.53
Common Stock
190.18190.18191.57159.68122.4792.64
Additional Paid-In Capital
510.05510.05518551.89554.93526.16
Retained Earnings
1,1441,1091,038994.95829.51685.11
Treasury Stock
---9.39-20.99-27.05-
Total Common Equity
1,8441,8091,7381,6861,4801,304
Minority Interest
142.66142.69174.71187.97--
Shareholders' Equity
1,9871,9521,9131,8731,4801,304
Total Liabilities & Equity
2,6502,5862,5862,4842,1211,674
Total Debt
70.6663.9118.5888.4413.4124.58
Net Cash (Debt)
414.93390.27389.78476629.28629.8
Net Cash Growth
5.17%0.12%-18.11%-24.36%-0.08%-17.84%
Net Cash Per Share
2.202.062.042.483.333.35
Filing Date Shares Outstanding
185.74192.6191.26191.61191.05187.87
Total Common Shares Outstanding
185.74192.6191.57191.61191.05187.87
Working Capital
694.44655.66603.54608.42829.92891.59
Book Value Per Share
9.939.399.078.807.756.94
Tangible Book Value
1,6751,6371,5581,4981,3961,214
Tangible Book Value Per Share
9.028.508.137.827.316.46
Buildings
--547.66395.67140.12127.89
Machinery
--480.99303.79174.84139.8
Construction In Progress
--269.34459.66340.89130.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.